Publicacións en colaboración con investigadores/as de Hospital Universitari de Girona Dr. Josep Trueta (83)

2024

  1. Systemic biomarker associated with poor outcome after futile reperfusion

    European Journal of Clinical Investigation, Vol. 54, Núm. 6

2020

  1. Cold stress protein RBM3 responds to hypothermia and is associated with good stroke outcome

    Brain Communications, Vol. 2, Núm. 2

2015

  1. The ARTICO study: Identification of patients at high risk of vascular recurrence after a first non-cardioembolic stroke

    BMC Neurology, Vol. 15, Núm. 1

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

2013

  1. Interleukin-10 facilitates the selection of patients for systemic thrombolysis

    BMC Neurology, Vol. 13

2012

  1. A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA)

    Clinical Science, Vol. 122, Núm. 3, pp. 113-119

  2. Citicoline in the treatment of acute ischaemic stroke: An international, randomised, multicentre, placebo-controlled study (ICTUS trial)

    The Lancet, Vol. 380, Núm. 9839, pp. 349-357

  3. Oxidative stress markers are associated to vascular recurrence in non-cardioembolic stroke patients non-treated with statins

    BMC Neurology, Vol. 12

  4. Usefulness of material recovered from distal embolic protection devices after carotid angioplasty for proteomic studies

    Journal of Vascular and Interventional Radiology, Vol. 23, Núm. 6, pp. 818-824

2011

  1. Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels

    Clinical Science, Vol. 121, Núm. 1, pp. 11-17

  2. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke

    Stroke, Vol. 42, Núm. 10, pp. 2813-2818

  3. High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1387-1393

  4. Impaired brachial flow-mediated dilation is a predictor of a new-onset vascular event after stroke

    Cerebrovascular Diseases, Vol. 32, Núm. 2, pp. 155-162

  5. Plan de asistencia sanitaria al ICTUS II. 2010

    Neurologia, Vol. 26, Núm. 7, pp. 383-396

  6. The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome

    Thrombosis and Haemostasis, Vol. 105, Núm. 3, pp. 421-429

  7. Value of carotid intima-media thickness and significant carotid stenosis as markers of stroke recurrence

    Stroke, Vol. 42, Núm. 11, pp. 3099-3104

2010

  1. Association of growth factors with arterial recanalization and clinical outcome in patients with ischemic stroke treated with tPA

    Journal of Thrombosis and Haemostasis, Vol. 8, Núm. 7, pp. 1567-1574

  2. Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: How well are we correcting it?: Implications for outcome

    Stroke, Vol. 41, Núm. 10, pp. 2362-2365

2009

  1. Age determines the effects of blood pressure lowering during the acute phase of ischemic stroke: The TICA study

    Hypertension, Vol. 54, Núm. 4, pp. 769-774

  2. Brachial arterial flow mediated dilation in acute ischemic stroke

    European Journal of Neurology, Vol. 16, Núm. 6, pp. 684-690